First, both MCD and MN showed a broadly concordant upregulation of the PD-1/PD-L1, CTLA-4/CD86 and CD200/CD200R axes across all three levels when compared with healthy volunteers, indicating a globally enhanced inhibitory checkpoint tone in primary glomerulopathies. The gene discussed is CD86; the disease is lipoprotein glomerulopathy.